Retatrutide, by Soma Pharmaceuticals , is receiving significant attention as a novel therapy for weight control . This innovative compound integrates the mechanism of a GLP-1 receptor agonist and a GIP receptor stimulant, designed to simply promote metabolic improvements but also improve underlyi